- Home
- RVMD vs TPG Comparison
RVMD vs TPG Comparison
Compare RVMD & TPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVMD
- TPG
- Stock Information
- Founded
- RVMD 2014
- TPG 1992
- Country
- RVMD United States
- TPG United States
- Employees
- RVMD N/A
- TPG N/A
- Industry
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- TPG Investment Managers
- Sector
- RVMD Health Care
- TPG Finance
- Exchange
- RVMD Nasdaq
- TPG Nasdaq
- Market Cap
- RVMD 7.5B
- TPG 6.2B
- IPO Year
- RVMD 2020
- TPG 2022
- Fundamental
- Price
- RVMD $36.63
- TPG $60.52
- Analyst Decision
- RVMD Strong Buy
- TPG Buy
- Analyst Count
- RVMD 12
- TPG 13
- Target Price
- RVMD $69.50
- TPG $61.67
- AVG Volume (30 Days)
- RVMD 1.5M
- TPG 1.7M
- Earning Date
- RVMD 08-06-2025
- TPG 08-06-2025
- Dividend Yield
- RVMD N/A
- TPG 2.89%
- EPS Growth
- RVMD N/A
- TPG N/A
- EPS
- RVMD N/A
- TPG N/A
- Revenue
- RVMD N/A
- TPG $3,710,887,000.00
- Revenue This Year
- RVMD N/A
- TPG N/A
- Revenue Next Year
- RVMD $234.26
- TPG $24.36
- P/E Ratio
- RVMD N/A
- TPG N/A
- Revenue Growth
- RVMD N/A
- TPG 44.34
- 52 Week Low
- RVMD $29.17
- TPG $37.52
- 52 Week High
- RVMD $62.40
- TPG $72.98
- Technical
- Relative Strength Index (RSI)
- RVMD 51.68
- TPG 65.41
- Support Level
- RVMD $36.20
- TPG $53.78
- Resistance Level
- RVMD $38.60
- TPG $59.48
- Average True Range (ATR)
- RVMD 1.25
- TPG 1.62
- MACD
- RVMD 0.09
- TPG -0.08
- Stochastic Oscillator
- RVMD 56.43
- TPG 93.34
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
About TPG TPG Inc.
TPG Inc is an alternative asset management firm. It invests across five multi-product platforms namely Capital, Growth, Impact, Real Estate, Market Solutions, and TPG Angelo Gordon. The company focuses on large-scale, control-oriented private equity investments.